Supernus: Q2 Earnings Snapshot
In this article:
ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Supernus Pharmaceuticals Inc. (SUPN) on Tuesday reported a loss of $831,000 in its second quarter.
The Rockville, Maryland-based company said it had a loss of 2 cents per share.
The drugmaker posted revenue of $135.6 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $145.2 million.
Supernus expects full-year revenue in the range of $580 million to $620 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SUPN at https://www.zacks.com/ap/SUPN
